Global Markets Direct’s, ‘Chronic Urticaria Or Hives Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Chronic Urticaria Or Hives, complete with latest updates, and special features on […]
December 2013 Life Science Industry Research Reports
Nasopharyngitis (Common Cold) – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Nasopharyngitis (Common Cold) Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Nasopharyngitis (Common Cold), complete with latest updates, and special features on late-stage and […]
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Mucopolysaccharidosis I (MPS I) (Hurler Syndrome), complete with latest updates, […]
Orthostatic Intolerance – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Orthostatic Intolerance Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Orthostatic Intolerance, complete with latest updates, and special features on late-stage and discontinued projects. […]
Nonmelanomatous Skin Cancer – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Nonmelanomatous Skin Cancer Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Nonmelanomatous Skin Cancer, complete with latest updates, and special features on late-stage and […]
Mitochondrial Diseases – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Mitochondrial Diseases Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Mitochondrial Diseases, complete with latest updates, and special features on late-stage and discontinued projects. […]
Corticosteroid-Responsive Dermatoses – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Corticosteroid-Responsive Dermatoses Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Corticosteroid-Responsive Dermatoses, complete with latest updates, and special features on late-stage and discontinued projects. […]
Bladder Carcinoma – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Bladder Carcinoma Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Bladder Carcinoma, complete with latest updates, and special features on late-stage and discontinued projects. […]
Corneal Neovascularization – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Corneal Neovascularization Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Corneal Neovascularization, complete with latest updates, and special features on late-stage and discontinued projects. […]
Leber Congenital Amaurosis (LCA) – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Leber Congenital Amaurosis (LCA) Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Leber Congenital Amaurosis (LCA), complete with latest updates, and special features on […]
Stay In Touch